Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Clinical Management of Brugada Syndrome: Commentary From the Experts. Circulation. Arrhythmia and electrophysiology Cutler, M. J., Eckhardt, L. L., Kaufman, E. S., Arbelo, E., Behr, E. R., Brugada, P., Cerrone, M., Crotti, L., DeAsmundis, C., Gollob, M. H., Horie, M., Huang, D. T., Krahn, A. D., London, B., Lubitz, S. A., Mackall, J. A., Nademanee, K., Perez, M. V., Probst, V., Roden, D. M., Sacher, F., Sarquella-Brugada, G., Scheinman, M. M., Shimizu, W., Shoemaker, B., Sy, R. W., Watanabe, A., Wilde, A. A. 2023: e012072

Abstract

Although there is consensus on the management of patients with Brugada Syndrome with high risk for sudden cardiac arrest, asymptomatic or intermediate-risk patients present clinical management challenges. This document explores the management opinions of experts throughout the world for patients with Brugada Syndrome who do not fit guideline recommendations. Four real-world clinical scenarios were presented with commentary from small expert groups for each case. All authors voted on case-specific questions to evaluate the level of consensus among the entire group in nuanced diagnostic and management decisions relevant to each case. Points of agreement, points of controversy, and gaps in knowledge are highlighted.

View details for DOI 10.1161/CIRCEP.123.012072

View details for PubMedID 38099441